News Release Details

Luminex is now a DiaSorin company
On July 14, Luminex became a part of the DiaSorin Group. Learn more about DiaSorin and the transaction here.
Your contacts for sales, service and customer support remain unchanged.
For further information or questions regarding the transaction, please contact ir@diasorin.it

Luminex Corporation Declares Second Quarter Cash Dividend

May 20, 2021 4:30 PM EDT

AUSTIN, Texas, May 20, 2021 /PRNewswire/ -- Luminex Corporation (Nasdaq:LMNX) (the "Company") today announced that its board of directors declared a cash dividend for the second quarter of 2021 of $0.10 per share of common stock payable on July 8, 2021 to stockholders of record as of the close of business June 17, 2021.

About Luminex Corporation
At Luminex, our mission is to empower labs to obtain reliable, timely, and actionable answers, ultimately advancing health.  We offer a wide range of solutions applicable in diverse markets including clinical diagnostics, pharmaceutical drug discovery, biomedical research, genomic and proteomic research, biodefense research, and food safety. We accelerate reliable answers while simplifying complexity and deliver certainty with a seamless experience. To learn more about Luminex, please visit us at www.luminexcorp.com.

Contacts:

Harriss Currie
Senior Vice President of Finance and
Chief Financial Officer
hcurrie@luminexcorp.com
512-219-8020

Carla Stanaford
Investor Relations
937-469-2120
cstanaford@luminexcorp.com

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/luminex-corporation-declares-second-quarter-cash-dividend-301296427.html

SOURCE Luminex Corporation

Shareholder Tools